Monday, February 27, 2023 5:52:51 AM
FUNDS Total (only for Top 20) 23.07% 20,851,795
ISTITUTIONS Total (only for Top 20) 74.41% 67,242,732
they charged them above $1
https://ih.advfn.com/stock-market/NASDAQ/rubius-therapeutics-RUBY/stock-news/87802292/rubius-therapeutics-ruby-gets-a-buy-rating-from-h
not even a year ago! Fool!
Have they waited until now for this?
but it's not worth shit!
Maybe one day like the vaccine it will come in handy but only to those who take it!
Right now it's worth nothing even if something seems to have yielded in terms of curing cancer!
Even if they have found a more sustainable formula!
Nothing!
Rubius has recently generated new non-human primate data with the next generation cell conjugation RED PLATFORM, demonstrating longer circulation time than observed with the first generation platform and pronounced pharmacodynamic effects as shown by increased levels of interferon gamma, a cytokine critical to both innate and adaptive immunity. In parallel, the Company has advanced a next generation Red Cell Therapeutic, RTX-250, an antigen-specific therapy that is designed to activate dendritic cells.
With the first generation Red Cell Therapeutics, Rubius demonstrated that engineered red blood cells could be manufactured at scale, safely administered and activate a patient’s immune system, resulting in clinical benefit in certain cancer patients, including evidence of tumor shrinkage and prolonged stable disease in PD-(L)-1 refractory solid tumors.
So why didn't istitutions sell?
IMO because there will be 30/40 million to distribute!
Let's hope they settle for free patents and leave us the cash!
ISTITUTIONS Total (only for Top 20) 74.41% 67,242,732
they charged them above $1
https://ih.advfn.com/stock-market/NASDAQ/rubius-therapeutics-RUBY/stock-news/87802292/rubius-therapeutics-ruby-gets-a-buy-rating-from-h
not even a year ago! Fool!
Have they waited until now for this?
but it's not worth shit!
Maybe one day like the vaccine it will come in handy but only to those who take it!
Right now it's worth nothing even if something seems to have yielded in terms of curing cancer!
Even if they have found a more sustainable formula!
Nothing!
Rubius has recently generated new non-human primate data with the next generation cell conjugation RED PLATFORM, demonstrating longer circulation time than observed with the first generation platform and pronounced pharmacodynamic effects as shown by increased levels of interferon gamma, a cytokine critical to both innate and adaptive immunity. In parallel, the Company has advanced a next generation Red Cell Therapeutic, RTX-250, an antigen-specific therapy that is designed to activate dendritic cells.
With the first generation Red Cell Therapeutics, Rubius demonstrated that engineered red blood cells could be manufactured at scale, safely administered and activate a patient’s immune system, resulting in clinical benefit in certain cancer patients, including evidence of tumor shrinkage and prolonged stable disease in PD-(L)-1 refractory solid tumors.
So why didn't istitutions sell?
IMO because there will be 30/40 million to distribute!
Let's hope they settle for free patents and leave us the cash!
Bullish
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
